| CPS Cito Pharma Services GmbH - Pegasys 135 mcg/0,5 ml, Injektionslösung in einer Fertigspritze | | 55585 | | 03 | | Pegasys 135 mcg/0,5 ml | | Injektionslösung in einer Fertigspritze | | L03AB11 | | Peginterferon Alfa-2a | | 25.10.2002 | | |
| | Composition | | peginterferonum alfa-2a 135 µg, natrii chloridum, alcohol benzylicus 5 mg, natrii acetas trihydricus, acidum aceticum glaciale, polysorbatum 80, natrii acetas trihydricus aut acidum aceticum ad pH, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml corresp. natrium 1.8 mg. | | Packungsbestandteile | | Injection solution in prefilled syringe | | | | | | | | Active Agent | Dose |
|---|
| Peginterferonum Alfa-2a | 135µg / 0.5ml |
| | BAG: Active Agent | Dose |
|---|
| Peginterferonum Alfa-2A | 135 mcg |
| | | | Inactive agents | Dose |
|---|
| Acidum Aceticum Glaciale | | | Alcohol Benzylicus | 5mg / 0.5ml | | Sodium Acetate Trihydrate | | | Natrii Acetas Trihydricus aut Acidum Aceticum ad Ph | | | Sodium Chloride | | | Polysorbatum 80 | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 012 | 4 x 0.5 ml | 617.82 | 688.35 | A | SL | No |
|
|
